Posted
Jun 18 2008, 09:19 AM
by
Dave Dispennette
Momentum Stocks
CYBX @ $22.37 (Cyberonics) develops an implantable device to treat epilepsy, depression and other debilitating neurological and psychiatric diseases. Heavy upside volume has made its way into this stock over the last few days, as the company closes in on announcing their first profit in a few years. They are expected to increase earnings 208% next year. We are establishing a quarter position here and will enter the second quarter on a pull back to the $20 level. The remaining half will be bought on any weakness that allows us to get in around $18.50 to $19. Our stop loss will be set at its rising 50 day moving average, currently $16.75.
This newsletter has been sent to you for informative purposes only and in no event should be construed as a representation by The Stock Playbook or its employees as an offer to sell or solicitation of an offer to buy any securities. The factual information given is taken from sources we believe to be reliable, but is not guaranteed as to its accuracy or completeness. The opinions expressed should be given only such weight as opinions warrant. employees and/or family members may have a position in the securities mentioned and may make purchase and/or sales of such securities from time to time in the open market or otherwise Recipients of The Stock Playbook prohibited from, directly or indirectly, distributing, forwarding , plagiarizing or copying any part of this message without expressed written consent from The Stock Playbook. Some content may have been based, at least in part, on material gathered from Investor's Business Daily ® and/or YAHOO!®